Genetic Testing and Treatment Options for Prostate Cancer in 2023

Exploration of genetic testing significance in stage 4 prostate cancer, focusing on Drimline testing standards and treatment strategies based on mutations such as BRCA2, utilizing PARP inhibitors and combination therapies for personalized care.